Estimation of a method detection limit for an in vivo XRF arsenic detection system

Physics in Medicine and Biology

Volumn 50, Issue 3, 2005, Pages 521-530

  Studinski, Ryan C N ^a   McNeill, Fiona E ^a   Chettle, David R ^a   O'Meara, Joanne M ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; COMPUTER SIMULATION; FLUORESCENCE; MONTE CARLO METHODS; SKIN; TISSUE; X RAYS;

CONJUNCTION; PHANTOMS; SUPERFICIAL LAYERS; X-RAY FLUORESCENCE MEASUREMENT SYSTEMS;

SYSTEMS ANALYSIS;

ARSENIC; IODINE 125;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IN VIVO STUDY; MALE; MEASUREMENT; MONTE CARLO METHOD; PHANTOM; PRIORITY JOURNAL; SKINFOLD THICKNESS; TISSUE LEVEL; X RAY FLUORESCENCE;

ARSENIC; CALIBRATION; ELECTRONICS; HUMANS; MODELS, THEORETICAL; MONTE CARLO METHOD; PHANTOMS, IMAGING; SCATTERING, RADIATION; SKIN; SOFTWARE; SPECTROMETRY, X-RAY EMISSION;

EID: 14544284561     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/50/3/009     Document Type: Article

References (32)

1. Ahlgren L, Lidén K, Mattsson S and Tejning S 1976 X-ray fluorescence analysis of lead in human skeleton in vivo Scand. J. Work Environ. Health 2 82-6
2. Ahlgren L and Mattsson S 1981 Cadmium in man measured in vivo by x-ray fluorescence analysis Phys. Med. Biol. 26 19-26
3. Bagshaw A P and Farquharson M J 2002 Simultaneous determination of iron, copper and zinc concentrations in skin phantoms using XRF spectrometry X-ray Spectrom. 31 47-52
4. Bevington P R 1969 Data Reduction and Error Analysis for the Physical Sciences (New York: McGraw-Hill)
5. Börjesson J, Barregård L, Sällsten G, Schütz A, Jonson R, Alpsten M and Mattsson S 1995 In vivo XRF analysis of mercury: the relation between concentrations in the kidney and the urine Phys. Med. Biol. 40 413-26
6. Chatterjee A, Das D, Mandal B K, Chowdhury T R, Samanta G and Chakraborti D 1995 Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world: Part 1. Arsenic species in drinking water and urine of the affected people Analyst 120 643-50
7. Chen C-J, Chiou H-Y, Chiang M-H, Lin L-J and Tai T-Y 1996 Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure Arterioscler Thromb. Vasc. Biol. 16 504-10
8. Ch'I IC and Blackwell R Q 1968 A controlled retrospective study of blackfoot disease, an endemic peripheral gangrene disease in Taiwan Am. J. Epidemiol. 88 7-24
9. Christoffersson J O and Mattsson S 1983 Polarised x-rays in XRF-analysis for improved in vivo detectability of cadmium in man Phys. Med. Biol. 28 1135-44
10. Das D, Chatterjee A, Mandal B K, Samanta G, Chakraborti D and Chanda B 1995 Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world: Part 2. Arsenic concentration in drinking water, hair, nails, urine, skin-scale and liver tissue (biopsy) of the affected people Analyst 120 917-24
11. Gordodetsky R, Goldfarb A, Dagan I and Rachmilewitz E A 1985 Noninvasive analysis of skin iron and zinc levels in β-thalassemia major and intermedia J. Lab. Clin. Med. 105 44-51
12. Guha Mazumder D N 2001 Arsenic and liver disease J. Indian Med. Assoc. 99 311-20
13. Harrington J M, Middaugh J P, Morse D L and Housworth J 1978 A survey of a population exposed to high concentrations of arsenic in well water in Fairbanks, Alaska Am. J. Epidemiol. 108 377-85
14. Hopenhayn C, Ferreccio C, Browning S R, Huang B, Peralta C, Gibb H and Hertz-Picciotto I 2003 Arsenic exposure from drinking water and birth weight Epidemiology 14 593-602
15. ICRP Publication-23 1975 Report of the Task Group on Reference Man (Oxford: Pergarnon)
16. Karim M M 2000 Arsenic in groundwater and health problems in Bangladesh Water Res. 34 304-10
17. Kyle R A and Pease G L 1965 Hematologic aspects of arsenic intoxication N. Engl. J. Med. 273 18-23
18. Lewis D R, Southwick J W, Ouellet-Hellstrom R, Rench J and Calderon R L 1999 Drinking water arsenic in Utah: a cohort mortality study Environ. Health Perspect. 107 359-65
19. Maes D and Pate B D 1977 The absorption of arsenic into single human head hairs J. Forensic Sci. 22 89-94
20. Marafante E and Vahter M 1987 Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster Environ. Res. 42 72-82
21. O'Meara J M, Chettle D R, McNeill F E, Prestwich W V and Svensson C E 1998 Monte Carlo simulation of source-excited in vivo x-ray fluorescence measurements of heavy metals Phys. Med. Biol. 43 1413-28
22. O'Meara J M, Chettle D R, McNeill F E and Webber C E 1997 The feasibility of measuring bone uranium concentrations in vivo using source excited K x-ray fluorescence Phys. Med. Biol. 42 1109-20
23. Pejović-Milić A, Stronach I M, Gyorffy J, Webber C E and Chettle D R 2004 Quantification of bone strontium levels in humans by in vivo x-ray fluorescence Med. Phys. 31 528-38
24. Ratnaike R N 2003 Acute and chronic arsenic toxicity Postgrad. Med. J. 79 391-6
25. Schoolmeester W L and White D R 1980 Arsenic poisoning South Med. J. 73 198-208
26. Schwartz R A 1997 Arsenic and the skin Int. J. Dermatol. 36 241-50
27. Smith A H, Hopenhayn-Rich C, Bates M N, Goeden H M, Hertz-Picciotto I, Duggan H M, Wood R, Kosnett M J and Smith M T 1992 Cancer risks from arsenic in drinking water Environ. Health Perspect. 97 259-67
28. Smith A H, Lingas E O and Rahman M 2000 Contamination of drinking-water by arsenic in Bangladesh: a public health emergency Bull. World Health Org. 78 1093-103
29. Somervaille L J, Chettle D R and Scott M C 1985 In vivo measurement of lead in bone using x-ray fluorescence Phys. Med. Biol. 30 929-43
30. Sun G 2004 Arsenic contamination and arsenicosis in China Toxicol. Appl. Pharmacol. 198 268-71
31. 74As) in humans following oral ingestion Toxicol. Appl. Pharmacol. 50 319-22
32. Vahter M, Concha G and Nermell B 2000 Factors influencing arsenic methylation in humans J. Trace Elem. Exp. Med. 13 173-84